29 related articles for article (PubMed ID: 10458239)
1. The central role of prognosis in clinical decision making.
Gill TM
JAMA; 2012 Jan; 307(2):199-200. PubMed ID: 22235093
[No Abstract] [Full Text] [Related]
2. Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma.
Huntington SF; von Keudell G; Davidoff AJ; Gross CP; Prasad SA
J Clin Oncol; 2018 Oct; 36(33):JCO1800122. PubMed ID: 30285558
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.
Guadagnolo BA; Punglia RS; Kuntz KM; Mauch PM; Ng AK
J Clin Oncol; 2006 Sep; 24(25):4116-22. PubMed ID: 16943528
[TBL] [Abstract][Full Text] [Related]
4. Costs and effectiveness of staging and treatment options in early-stage Hodgkin's disease.
Ng AK; Kuntz KM; Mauch PM; Weeks JC
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):979-89. PubMed ID: 11429226
[TBL] [Abstract][Full Text] [Related]
5. Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis.
Telford JJ; Saltzman JR; Kuntz KM; Syngal S
J Natl Cancer Inst; 2004 Feb; 96(3):191-201. PubMed ID: 14759986
[TBL] [Abstract][Full Text] [Related]
6. Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: a decision analysis.
Ng AK; Weeks JC; Mauch PM; Kuntz KM
J Clin Oncol; 1999 Jan; 17(1):241-52. PubMed ID: 10458239
[TBL] [Abstract][Full Text] [Related]
7. Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease.
Ng AK; Weeks JC; Mauch PM; Kuntz KM
J Clin Oncol; 1999 Nov; 17(11):3577-85. PubMed ID: 10550157
[TBL] [Abstract][Full Text] [Related]
8. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis.
Prica A; Chan K; Cheung MC
Br J Haematol; 2012 Sep; 158(5):600-7. PubMed ID: 22734565
[TBL] [Abstract][Full Text] [Related]
9. [Hodgkin's lymphoma: problems in the treatment of the early stages].
Bacigalupo A; Barra S; Corvò R; Guenzi M; Scolaro T; Vitale V
Radiol Med; 1996 Nov; 92(5):620-3. PubMed ID: 9036456
[TBL] [Abstract][Full Text] [Related]
10. Substaging of stage III Hodgkin's disease.
Farah R; Weichselbaum RR
Hematol Oncol Clin North Am; 1989 Jun; 3(2):277-86. PubMed ID: 2663828
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
